Quipt Enterprise Value vs Market Cap Analysis

QIPT Stock

USD 2.82 0.08 2.92%

Quipt Home financial indicator trend analysis is much more than just breaking down Quipt Home Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quipt Home Medical is a good investment. Please check the relationship between Quipt Home Enterprise Value and its Market Cap accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quipt Home Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Enterprise Value vs Market Cap

Enterprise Value vs Market Cap Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quipt Home Medical Enterprise Value account and Market Cap. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Quipt Home's Enterprise Value and Market Cap is 0.96. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Market Cap in the same time period over historical financial statements of Quipt Home Medical, assuming nothing else is changed. The correlation between historical values of Quipt Home's Enterprise Value and Market Cap is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Quipt Home Medical are associated (or correlated) with its Market Cap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Market Cap has no effect on the direction of Enterprise Value i.e., Quipt Home's Enterprise Value and Market Cap go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Enterprise Value

Enterprise Value (or EV) is usually referred to as Quipt Home theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Quipt Home Medical debt, but would also pocket its cash. Enterprise Value is more accurate representation of Quipt Home value than its market capitalization because it takes into account all of Quipt Home Medical existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Market Cap

Most indicators from Quipt Home's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quipt Home Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quipt Home Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

At this time, Quipt Home's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 80.3 K in 2024, whereas Enterprise Value Over EBITDA is likely to drop 6.75 in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	139.9M	221.7M	255.0M	267.8M
Interest Expense	2.1M	6.6M	7.6M	8.0M

Total Revenue Interest Expense

Quipt Home fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Current Liab	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Short Term Debt	Current Deferred Revenue	Accounts Payable
Total Assets		0.96	0.93	0.97	0.8	-0.52	0.51	0.98	0.77	0.51	0.97	0.86	-0.26	0.4	0.94	0.86	0.88	0.9	0.42	0.97	0.89	0.95	0.07	0.9	0.02	0.93
Total Current Liabilities	0.96		0.81	0.98	0.85	-0.66	0.44	0.94	0.8	0.44	0.92	0.95	-0.26	0.5	0.97	0.81	0.92	0.93	0.5	0.91	0.92	0.99	0.11	0.98	-0.05	0.98
Total Stockholder Equity	0.93	0.81		0.84	0.56	-0.39	0.57	0.89	0.55	0.57	0.92	0.72	-0.28	0.41	0.75	0.87	0.81	0.69	0.39	0.9	0.68	0.82	0.15	0.72	0.04	0.75
Property Plant And Equipment Net	0.97	0.98	0.84		0.87	-0.64	0.38	0.97	0.79	0.38	0.96	0.93	-0.27	0.48	0.97	0.77	0.92	0.93	0.4	0.92	0.92	0.98	0.02	0.97	-0.09	0.98
Net Debt	0.8	0.85	0.56	0.87		-0.49	0.05	0.84	0.88	0.05	0.76	0.76	-0.08	0.25	0.92	0.54	0.71	0.96	0.16	0.77	0.94	0.83	-0.04	0.91	-0.16	0.92
Retained Earnings	-0.52	-0.66	-0.39	-0.64	-0.49		-0.27	-0.47	-0.32	-0.27	-0.56	-0.85	0.38	-0.46	-0.57	-0.54	-0.84	-0.54	-0.52	-0.39	-0.47	-0.67	-0.24	-0.69	0.44	-0.6
Cash	0.51	0.44	0.57	0.38	0.05	-0.27		0.45	0.28	1.0	0.49	0.42	-0.29	-0.01	0.4	0.58	0.47	0.34	0.64	0.5	0.35	0.37	-0.08	0.3	0.4	0.34
Non Current Assets Total	0.98	0.94	0.89	0.97	0.84	-0.47	0.45		0.81	0.45	0.97	0.84	-0.21	0.41	0.95	0.74	0.84	0.92	0.32	0.99	0.92	0.93	-0.1	0.92	0.04	0.94
Non Currrent Assets Other	0.77	0.8	0.55	0.79	0.88	-0.32	0.28	0.81		0.28	0.71	0.67	-0.16	0.1	0.89	0.52	0.6	0.91	0.28	0.78	0.92	0.76	-0.14	0.82	0.2	0.86
Cash And Short Term Investments	0.51	0.44	0.57	0.38	0.05	-0.27	1.0	0.45	0.28		0.49	0.42	-0.29	-0.01	0.4	0.58	0.47	0.34	0.64	0.5	0.35	0.37	-0.08	0.3	0.4	0.34
Net Receivables	0.97	0.92	0.92	0.96	0.76	-0.56	0.49	0.97	0.71	0.49		0.86	-0.32	0.43	0.9	0.78	0.89	0.86	0.33	0.95	0.85	0.92	-0.07	0.89	-0.01	0.91
Common Stock Shares Outstanding	0.86	0.95	0.72	0.93	0.76	-0.85	0.42	0.84	0.67	0.42	0.86		-0.36	0.55	0.89	0.76	0.97	0.84	0.56	0.78	0.81	0.95	0.16	0.95	-0.19	0.91
Short Term Investments	-0.26	-0.26	-0.28	-0.27	-0.08	0.38	-0.29	-0.21	-0.16	-0.29	-0.32	-0.36		-0.15	-0.21	-0.36	-0.37	-0.16	-0.2	-0.19	-0.17	-0.25	-0.14	-0.23	-0.41	-0.23
Other Stockholder Equity	0.4	0.5	0.41	0.48	0.25	-0.46	-0.01	0.41	0.1	-0.01	0.43	0.55	-0.15		0.35	0.3	0.51	0.23	0.25	0.42	0.22	0.58	0.14	0.52	-0.15	0.45
Total Liab	0.94	0.97	0.75	0.97	0.92	-0.57	0.4	0.95	0.89	0.4	0.9	0.89	-0.21	0.35		0.74	0.84	0.98	0.4	0.91	0.98	0.94	-0.01	0.97	0.01	0.99
Total Current Assets	0.86	0.81	0.87	0.77	0.54	-0.54	0.58	0.74	0.52	0.58	0.78	0.76	-0.36	0.3	0.74		0.83	0.68	0.61	0.72	0.66	0.8	0.51	0.69	-0.03	0.73
Common Stock	0.88	0.92	0.81	0.92	0.71	-0.84	0.47	0.84	0.6	0.47	0.89	0.97	-0.37	0.51	0.84	0.83		0.8	0.55	0.79	0.75	0.93	0.21	0.9	-0.23	0.86
Short Long Term Debt Total	0.9	0.93	0.69	0.93	0.96	-0.54	0.34	0.92	0.91	0.34	0.86	0.84	-0.16	0.23	0.98	0.68	0.8		0.34	0.87	0.99	0.89	-0.06	0.94	-0.03	0.96
Other Current Liab	0.42	0.5	0.39	0.4	0.16	-0.52	0.64	0.32	0.28	0.64	0.33	0.56	-0.2	0.25	0.4	0.61	0.55	0.34		0.31	0.3	0.48	0.39	0.42	0.13	0.4
Good Will	0.97	0.91	0.9	0.92	0.77	-0.39	0.5	0.99	0.78	0.5	0.95	0.78	-0.19	0.42	0.91	0.72	0.79	0.87	0.31		0.87	0.9	-0.13	0.87	0.12	0.89
Non Current Liabilities Total	0.89	0.92	0.68	0.92	0.94	-0.47	0.35	0.92	0.92	0.35	0.85	0.81	-0.17	0.22	0.98	0.66	0.75	0.99	0.3	0.87		0.88	-0.1	0.93	0.05	0.96
Inventory	0.95	0.99	0.82	0.98	0.83	-0.67	0.37	0.93	0.76	0.37	0.92	0.95	-0.25	0.58	0.94	0.8	0.93	0.89	0.48	0.9	0.88		0.15	0.97	-0.11	0.97
Other Current Assets	0.07	0.11	0.15	0.02	-0.04	-0.24	-0.08	-0.1	-0.14	-0.08	-0.07	0.16	-0.14	0.14	-0.01	0.51	0.21	-0.06	0.39	-0.13	-0.1	0.15		0.02	-0.29	0.02
Short Term Debt	0.9	0.98	0.72	0.97	0.91	-0.69	0.3	0.92	0.82	0.3	0.89	0.95	-0.23	0.52	0.97	0.69	0.9	0.94	0.42	0.87	0.93	0.97	0.02		-0.11	0.98
Current Deferred Revenue	0.02	-0.05	0.04	-0.09	-0.16	0.44	0.4	0.04	0.2	0.4	-0.01	-0.19	-0.41	-0.15	0.01	-0.03	-0.23	-0.03	0.13	0.12	0.05	-0.11	-0.29	-0.11		-0.04
Accounts Payable	0.93	0.98	0.75	0.98	0.92	-0.6	0.34	0.94	0.86	0.34	0.91	0.91	-0.23	0.45	0.99	0.73	0.86	0.96	0.4	0.89	0.96	0.97	0.02	0.98	-0.04

Click cells to compare fundamentals

Quipt Home Account Relationship Matchups

Quipt Home fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.9M	108.6M	132.2M	247.4M	284.5M	298.7M
Total Current Liabilities	18.3M	32.7M	41.7M	60.6M	69.7M	73.1M
Total Stockholder Equity	21.1M	58.6M	79.5M	111.1M	127.8M	134.2M
Property Plant And Equipment Net	12.5M	23.5M	33.5M	53.4M	61.4M	64.5M
Net Debt	(4.7M)	(7.6M)	2.4M	80.8M	92.9M	97.5M
Retained Earnings	(124.6M)	(165.9M)	(161.0M)	(163.8M)	(147.4M)	(140.1M)
Cash	21.9M	34.6M	8.5M	17.2M	19.8M	20.8M
Non Current Assets Total	20.1M	51.3M	90.7M	182.0M	209.3M	219.7M
Non Currrent Assets Other	480.3K	504K	86K	1.7M	2.0M	2.1M
Other Assets	94K	856K	504K	86K	98.9K	105.9K
Cash And Short Term Investments	21.9M	34.6M	8.5M	17.2M	19.8M	20.8M
Net Receivables	6.8M	11.9M	16.4M	26.0M	29.9M	31.4M
Common Stock Shares Outstanding	22.7M	30.4M	36.3M	38.6M	44.4M	46.6M
Liabilities And Stockholders Equity	53.9M	108.6M	132.2M	247.4M	284.5M	298.7M
Other Stockholder Equity	(27.6M)	21.7M	116.9M	27.4M	31.5M	33.1M
Total Liab	32.8M	50.0M	52.7M	136.3M	156.7M	164.6M
Total Current Assets	33.9M	57.2M	41.5M	65.4M	75.2M	79.0M
Common Stock	126.0M	202.8M	214.3M	247.5M	284.7M	298.9M
Short Long Term Debt Total	17.2M	27.1M	10.9M	98.0M	112.7M	118.3M
Other Current Liab	7.5M	31.5M	9.2M	8.8M	10.1M	10.6M
Good Will	2.9M	12.5M	28.2M	52.8M	60.7M	63.8M
Non Current Liabilities Total	14.6M	17.2M	10.9M	75.7M	87.1M	91.4M
Inventory	4.8M	9.3M	15.6M	18.4M	21.2M	22.2M
Other Current Assets	11.8M	16.7M	16.6M	3.8M	4.4M	5.3M
Short Term Debt	5.3M	10.0M	15.6M	22.6M	26.0M	27.3M
Current Deferred Revenue	3.3M	7.3M	3.0M	4.5M	5.2M	5.4M
Accounts Payable	5.6M	9.8M	13.8M	24.7M	28.4M	29.9M
Intangible Assets	4.2M	14.9M	28.9M	74.0M	85.1M	89.4M
Net Tangible Assets	12.5M	25.0M	31.3M	22.5M	20.2M	25.2M
Long Term Debt	13.3M	12.3M	3.7M	61.3M	70.5M	74.1M
Capital Lease Obligations	5.2M	7.8M	10.5M	19.2M	22.0M	23.1M
Net Invested Capital	45.8M	77.9M	95.6M	189.9M	218.4M	229.3M
Property Plant And Equipment Gross	16.6M	45.1M	57.1M	94.0M	108.1M	113.5M
Net Working Capital	20.8M	24.5M	(204K)	4.9M	4.4M	4.2M
Property Plant Equipment	19.5M	22.2M	23.5M	33.5M	38.5M	25.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Quipt Stock Analysis

When running Quipt Home's price analysis, check to measure Quipt Home's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quipt Home is operating at the current time. Most of Quipt Home's value examination focuses on studying past and present price action to predict the probability of Quipt Home's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quipt Home's price. Additionally, you may evaluate how the addition of Quipt Home to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC